Magellan Health (MGLN) Tops Q3 EPS by 16c; Boosts FY15 EPS Outlook
Tweet Send to a Friend
Magellan Health (NASDAQ: MGLN) reported Q3 EPS of $0.76, $0.16 better than the analyst estimate of $0.60. Revenue for the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
